Bioceres Q3 Revenue Plunges 23%, Posts $10M Loss; Foreclosure Adds to Woes
BIOX sits 61% above its 52-week low of $0.347.
Summary
Bioceres Crop Solutions reported significantly negative fiscal third-quarter 2026 results, with total revenues declining 23% year-over-year to $39.4 million. The company posted a net loss of $10.0 million, a sharp reversal from a $2.3 million profit in the prior year, and Adjusted EBITDA turned negative at $(0.6) million. Adding to the financial challenges, the company's Pro Farm Group business was subject to a foreclosure auction and has been classified as discontinued operations, with ongoing litigation creating further uncertainty. These results indicate substantial operational headwinds and a deteriorating financial position, which will likely weigh heavily on investor sentiment. Traders will be closely watching for updates on the company's liability management initiatives, strategic review, and the resolution of the Pro Farm litigation.
At the time of this announcement, BIOX was trading at $0.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $34.3M. The 52-week trading range was $0.35 to $5.18. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.